Research on Hemolytic Anemia Detailed by a Researcher at University of Miami (Targeting Complement Inhibition in Cold Hemolysis; A Multifaceted Approach Using Sutimlimab and Washed Red Cell Transfusions).

MLA

“Research on Hemolytic Anemia Detailed by a Researcher at University of Miami (Targeting Complement Inhibition in Cold Hemolysis; A Multifaceted Approach Using Sutimlimab and Washed Red Cell Transfusions).” Medical Letter on the CDC & FDA, Dec. 2023, p. 721. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=174244477&authtype=sso&custid=ns315887.

APA

Research on Hemolytic Anemia Detailed by a Researcher at University of Miami (Targeting Complement Inhibition in Cold Hemolysis; A Multifaceted Approach Using Sutimlimab and Washed Red Cell Transfusions). (2023). Medical Letter on the CDC & FDA, 721.

Chicago

“Research on Hemolytic Anemia Detailed by a Researcher at University of Miami (Targeting Complement Inhibition in Cold Hemolysis; A Multifaceted Approach Using Sutimlimab and Washed Red Cell Transfusions).” 2023. Medical Letter on the CDC & FDA, December, 721. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=174244477&authtype=sso&custid=ns315887.